高级检索+

肝细胞癌CASP1基因的生物信息学分析及基因敲减研究

Bioinformatics Analyses of CASP1 Gene in Hepatocellular Carcinoma and Study of Gene Knockdown

  • 摘要: 本研究旨在通过生物信息学方法分析肝细胞癌(hepatocellular carcinoma, HCC)半胱氨酸天冬氨酸特异性蛋白酶-1(cysteinyl aspartate specific proteinase-1, caspase-1,CASP1)基因的功能,及敲减CASP1对HCC细胞的影响。利用UALCAN、 the Human Protein Atlas和LinkedOmics等数据库分析CASP1在临床HCC组织中的表达情况及其与HCC患者总生存期(overall survival, OS)的关系,并对患者HCC组织中CASP1共表达基因集进行GO和KEGG通路富集分析。采用CRISPR/Cas9系统敲减HepG2细胞的CASP1基因,并通过测序、 RT-PCR和Western blot确认敲减效果。分别采用CCK-8、 Transwell和Annexin V-FITC/PI双染法检测CASP1基因敲减对HepG2细胞增殖、侵袭与凋亡的影响。结果显示,与正常肝组织或不含TP53基因突变的HCC组织相比,CASP1 mRNA表达水平在含有TP53基因突变的HCC组织中显著升高(P<0.01)。CASP1 mRNA高表达的HCC患者OS减少(P=0.033);临床Ⅰ期、Ⅱ期的患者HCC组织CASP1 mRNA水平越高,患者的OS越短(P=0.023 2),而临床Ⅲ期、Ⅳ期患者HCC组织CASP1 mRNA水平变化对患者OS的影响差异不显著(P=0.471 3)。CASP1共表达基因集富集分析显示其主要与免疫反应(特别是NK细胞和吞噬细胞等介导的固有免疫应答,以及T细胞介导的特异性免疫应答)有关。CASP1敲减后,HepG2细胞的增殖能力下降、侵袭能力增强、细胞凋亡减少。以上结果表明CASP1在HCC中具有致癌和抑癌双重功能,HCC细胞内CASP1的下调可能抑制癌细胞增殖,但有助于其存活及侵袭能力的增强。

     

    Abstract: This study aimed to analyze gene function of cysteinyl aspartate specific proteinase-1(caspase-1, CASP1) gene in hepatocellular carcinoma(HCC) based on bioinformatics analyses and the effect of CASP1 knockdown on liver cancer cells. CASP1 expression in human HCC tissues and the relationship between CASP1 and overall survival(OS) of liver cancer patients were analyzed by UALCAN, the Human Protein Atlas and LinkedOmics databases. The GO and KEGG enrichment analyses were conducted for the co-expression gene set of CASP1. The CASP1 gene was knocked down by CRISPR/Cas9 system in the HepG2 cell. Sequencing, RT-PCR and western blotting were used to confirm the knockdown. The CCK-8 assay, transwell assay and Annexin V-FITC/PI double-stained assay were employed to detect the effect of CASP1 knockdown on cell proliferation, cell invasion and cell apoptosis of HepG2 cells. The results showed that CASP1 mRNA expression levels were significantly higher in tissues from HCC patients with TP53 gene mutation(P<0.01), compared with normal tissues and those of patients without TP53 gene mutations. HCC patients with high expression of CASP1 had a significantly reduced OS(P=0.033). High CASP1 expression was further associated with a reduced OS among patients in clinical stage Ⅰ and stage Ⅱ(P=0.023 2). There was no significant difference in OS according to CASP1 expression among patients in clinical stage Ⅲ and stage Ⅳ(P=0.471 3). The enrichment analyses of the co-expression gene set of CASP1 showed that they were associated with immune responses(especially for innate immune responses mediated by NK cells and phagocytes, and adaptive immune responses mediated by T cells). After the CASP1 gene was knocked down, the proliferative ability of cells increased, the invasion abi-lity of cells was enhanced and decreased apoptosis occurred in HepG2 cell. In summary, CASP1 has both oncogenic and tumor suppressor functions in HCC. Downregulation of CASP1 in HCC cells may inhibit cell proliferation, but enhance cell survival and invasion abilities.

     

/

返回文章
返回